The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial

Table 2 Percent change from baseline in LDL-C, TC and HDL-C between intervention and control groups

Time point	Outcomes	LS Mean (SE)		Difference in LS Means (%)
Time point	Outcomes	PCP-NE (n=132)	PCP (n=131)	PCP-NE versus PCP	95% Cl (%)	p-value
Week 24	LDL-C	−30.09 (2.03)	−27.54 (2.03)	−2.55	−7.26, 2.16	0.288
	TC	−22.97 (1.55)	−20.80 (1.54)	−2.17	−5.72, 1.38	0.229
	HDL-C	−2.60 (1.30)	−5.61 (1.30)	3.01	0.12, 5.90	0.041
Week 36	LDL-C	−25.88 (2.03)	−26.86 (2.03)	0.98	−3.68, 5.65	0.679
	TC	−19.94 (1.53)	−19.97 (1.52)	0.04	−3.43, 3.51	0.984
	HDL-C	−2.97 (1.42)	−5.44 (1.41)	2.48	−0.79, 5.74	0.136

LS = Least Squares; SE = Standard Error; 95%; CI = 95% Confidence Interval; LDL-C = Low Density Lipoprotein Cholesterol; TC = Total Cholesterol; HDL-C = High Density Lipoprotein Cholesterol; PCP = Primary Care Physicians; PCP-NE = Primary Care Physicians assisted by Nurse Educators.